W 274 (Lamotrigine Extended-Release 50 mg)
Pill with imprint W 274 is Pink, Round and has been identified as Lamotrigine Extended-Release 50 mg. It is supplied by Wockhardt USA LLC.
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; anxiety; epilepsy (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for W 274
Lamotrigine Extended-Release
- Imprint:
- W 274
- Strength:
- 50 mg
- Color:
- Pink
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Wockhardt USA LLC
- Inactive Ingredients:
- diethyl phthalate
ferric oxide red
hypromelloses
lactose monohydrate
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol
magnesium silicate
titanium dioxide
Note: Inactive ingredients may vary.
More about lamotrigine
- Lamotrigine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 963 Reviews
- Drug class: triazine anticonvulsants
- FDA Alerts (4)
Consumer resources
- Lamotrigine
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Tablets
- Lamotrigine (Advanced Reading)
Other brands: Lamictal, Lamictal XR, Lamictal CD, Lamictal ODT, Subvenite
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
